PSYCHIATRIC COMORBIDITIES IN ATOPIC DERMATITIS – A NARRATIVE REVIEW FOCUSING ON DEPRESSION AND ANXIETY
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5415Keywords:
Atopic Dermatitis, Eczema, Depression, Anxiety, Psychological Impact, Quality of LifeAbstract
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease, affecting both children and adults worldwide. Beyond its dermatological manifestations, AD often leads to sleep disturbances, persistent itch, and discomfort, which may contribute to elevated levels of anxiety and depression. The disease’s relapsing course and visible skin lesions can further impact social functioning and quality of life, highlighting the need to understand its psychological burden. This review aims to summarize current evidence on the impact of pruritus and sleep disturbances on depression and anxiety in patients with atopic dermatitis, explore potential biological mechanisms, and discuss their effects on patients’ quality of life and clinical implications.
Methods: A narrative literature review was conducted using PubMed and Google Scholar, including original studies, population-based analyses, clinical trials, and relevant reviews addressing psychological outcomes in both paediatric and adult populations.
Results: Depression and anxiety are among the most common psychiatric comorbidities in AD, with prevalence estimates showing considerable variability across studies. Their occurrence and severity are closely associated with disease severity, chronic pruritus, and sleep disturbances. Pruritus and sleep disruption emerge as key mediators linking dermatological symptoms with psychological distress. In addition to psychosocial factors such as visible skin lesions and social stigma, biological mechanisms—including immune dysregulation, increased pro-inflammatory cytokine activity, and alterations of the hypothalamic–pituitary–adrenal axis—may contribute to increased vulnerability to mood disorders.
Conclusions: Despite the high prevalence of psychiatric symptoms, mental health assessment remains insufficiently integrated into routine AD care. Early identification and multidisciplinary management are essential. Future research should focus on prospective studies evaluating integrated therapeutic approaches to improve both mental health outcomes and overall quality of life in patients with AD.
References
Bawany, F., Northcott, C. A., Beck, L. A., & Pigeon, W. R. (2021). Sleep disturbances and atopic dermatitis: Relationships, methods for assessment, and therapies. Journal of Allergy and Clinical Immunology: In Practice, 9(4), 1488–1500. https://doi.org/10.1016/j.jaip.2020.12.007
Buske-Kirschbaum, A., Geiben, A., Höllig, H., Morschhäuser, E., & Hellhammer, D. (2002). Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. The Journal of Clinical Endocrinology and Metabolism, 87(9), 4245–4251. https://doi.org/10.1210/jc.2001-010872
Carr, S., Pratt, R., White, F., & Watson, W. (2024). Atopic dermatitis. Allergy, Asthma & Clinical Immunology, 20(Suppl. 3), Article 63. https://doi.org/10.1186/s13223-024-00927-2
Chatrath, S., Loiselle, A. R., Johnson, J. K., & Begolka, W. S. (2024). Evaluating mental health support by healthcare providers for patients with atopic dermatitis: A cross-sectional survey. Skin Health and Disease, 4(5). https://doi.org/10.1002/ski2.408
Chrostowska-Plak, D., Reich, A., & Szepietowski, J. C. (2013). Relationship between itch and psychological status of patients with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 27(2). https://doi.org/10.1111/j.1468-3083.2012.04578.x
Courtney, A., & Su, J. C. (2024). The psychology of atopic dermatitis. Journal of Clinical Medicine, 13(6). https://doi.org/10.3390/jcm13061602
Farzanfar, D., Dowlati, Y., French, L. E., Lowes, M. A., & Alavi, A. (2018). Inflammation: A contributor to depressive comorbidity in inflammatory skin disease. Skin Pharmacology and Physiology, 31(5), 246–251. https://doi.org/10.1159/000490002
Fasseeh, A. N., Elezbawy, B., Korra, N., Tannira, M., Dalle, H., Aderian, S., Abaza, S., & Kaló, Z. (2022). Burden of atopic dermatitis in adults and adolescents: A systematic literature review. Dermatology and Therapy, 12(12), 2653–2668. https://doi.org/10.1007/s13555-022-00819-6
Fishbein, A. B., Cheng, B. T., Tilley, C. C., Begolka, W. S., Carle, A. C., Forrest, C. B., Zee, P. C., Paller, A. S., & Griffith, J. W. (2021). Sleep disturbance in school-aged children with atopic dermatitis: Prevalence and severity in a cross-sectional sample. Journal of Allergy and Clinical Immunology: In Practice, 9(8), 3120–3129.e3. https://doi.org/10.1016/j.jaip.2021.04.064
Geng, B., Mehta, V., Paller, A., Alexis, A., Irvine, A., Flohr, C., Torello, A., Dawson, Z., Pierce, E., Agell, H., Zhang, H., Qiao, M., & Boguniewicz, M. (2025). Lebrikizumab improves anxiety and depression symptoms of adolescents with moderate-to-severe atopic dermatitis: Results from a 52-week, open-label, phase 3 study. Journal of Allergy and Clinical Immunology, 155(2), AB200. https://doi.org/10.1016/j.jaci.2024.12.620
Gonzalez-Uribe, V., Vidaurri-De la Cruz, H., Gomez-Nuñez, A., Leyva-Calderon, J. A., & Mojica-Gonzalez, Z. S. (2023). Comorbidities and burden of disease in atopic dermatitis. Asian Pacific Journal of Allergy and Immunology, 41(2), 97–105. https://doi.org/10.12932/ap-231022-1484
Hartono, S. P., Chatrath, S., Aktas, O. N., Kubala, S. A., Capozza, K., Myles, I. A., Silverberg, J. I., & Schwartz, A. (2024). Interventions for anxiety and depression in patients with atopic dermatitis: A systematic review and meta-analysis. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-59162-9
Katamanin, O. M., Tan, I. J., Barry, J., & Jafferany, M. (2025). Role of inflammation and cytokine dysregulation in depression in patients with inflammatory skin conditions. American Journal of Clinical Dermatology, 26(1), 35–43. https://doi.org/10.1007/s40257-024-00905-9
Kelly, K. A., Balogh, E. A., Kaplan, S. G., & Feldman, S. R. (2021). Skin disease in children: Effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients. Children, 8(11). https://doi.org/10.3390/children8111057
Kim, S. H., Hur, J., Jang, J. Y., Park, H. S., Hong, C. H., Son, S. J., & Chang, K. J. (2015). Psychological distress in young adult males with atopic dermatitis: A cross-sectional study. Medicine, 94(23), e949. https://doi.org/10.1097/MD.0000000000000949
Kobusiewicz, A. K., Tarkowski, B., Kaszuba, A., Lesiak, A., Narbutt, J., & Zalewska-Janowska, A. (2023). The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional study. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1066495
Langan, S. M., Irvine, A. D., & Weidinger, S. (2020). Atopic dermatitis. The Lancet, 396(10247), 345–360. https://doi.org/10.1016/S0140-6736(20)31286-1
LeBovidge, J. S., & Schneider, L. C. (2025). Depression and anxiety in patients with atopic dermatitis: Recognizing and addressing mental health burden. Annals of Allergy, Asthma & Immunology, 134(5), 506–515. https://doi.org/10.1016/j.anai.2025.02.017
Legat, F. J. (2021). Itch in atopic dermatitis—What is new? Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.644760
Lin, K. H., Chang, Y. J., Chang, T. M., Yang, K. D., Lin, C. Y., Lue, K. H., Sun, H. L., Liao, P. F., Kao, J. K., & Tsai, Y. G. (2026). Impact of sleep disturbance on mental health in schoolchildren with atopic dermatitis: A population-based study. JAAD International, 24, 50–60. https://doi.org/10.1016/j.jdin.2025.08.013
Lin, T. K., Zhong, L., & Santiago, J. L. (2017). Association between stress and the HPA axis in atopic dermatitis. International Journal of Molecular Sciences, 18(10). https://doi.org/10.3390/ijms18102131
Linares-Gonzalez, L., Lozano-Lozano, I., Gutierrez-Rojas, L., Lozano-Lozano, M., Rodenas-Herranz, T., & Ruiz-Villaverde, R. (2021). Sexual dysfunction and atopic dermatitis: A systematic review. Life, 11(12). https://doi.org/10.3390/life11121314
Liu, K., Gao, W., Lu, H.-G., & Chen, Z.-G. (2025). Risk factors for anxiety and depression in patients with atopic dermatitis and their impact on prognosis. World Journal of Psychiatry, 15(6). https://doi.org/10.5498/wjp.v15.i6.104738
Mack, M. R., & Kim, B. S. (2018). The itch–scratch cycle: A neuroimmune perspective. Trends in Immunology, 39(12), 980. https://doi.org/10.1016/j.it.2018.10.001
Marron, S. E., Cebrian-Rodriguez, J., Alcalde-Herrero, V. M., Garcia-Latasa de Aranibar, F. J., & Tomas-Aragones, L. (2020). Psychosocial impact of atopic dermatitis in adults: A qualitative study. Actas Dermo-Sifiliográficas (English Edition), 111(6), 513–517. https://doi.org/10.1016/j.adengl.2019.03.030
Miniotti, M., Lazzarin, G., Ortoncelli, M., Mastorino, L., Ribero, S., & Leombruni, P. (2022). Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of dupilumab treatment for moderate-to-severe atopic dermatitis. Dermatologic Therapy, 35(5). https://doi.org/10.1111/dth.15407
Nicholas, M. N., & Gooderham, M. J. (2017). Atopic dermatitis, depression, and suicidality. Journal of Cutaneous Medicine and Surgery, 21(3), 237–242. https://doi.org/10.1177/1203475416685078
Radtke, S., Grossberg, A. L., & Wan, J. (2023). Mental health comorbidity in youth with atopic dermatitis: A narrative review of possible mechanisms. Pediatric Dermatology, 40(6), 977–982. https://doi.org/10.1111/pde.15410
Ramirez, F. D., Chen, S., Langan, S. M., Prather, A. A., McCulloch, C. E., Kidd, S. A., Cabana, M. D., Chren, M. M., & Abuabara, K. (2019). Association of atopic dermatitis with sleep quality in children. JAMA Pediatrics, 173(5), e190025. https://doi.org/10.1001/jamapediatrics.2019.0025
Salfi, F., Amicucci, G., Ferrara, M., Tempesta, D., De Berardinis, A., Chiricozzi, A., Peris, K., Fargnoli, M. C., & Esposito, M. (2023). The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients. Archives of Dermatological Research, 315(6), 1577–1582. https://doi.org/10.1007/s00403-023-02538-0
Schonmann, Y., Mansfield, K. E., Hayes, J. F., Abuabara, K., Roberts, A., Smeeth, L., & Langan, S. M. (2020). Atopic eczema in adulthood and risk of depression and anxiety: A population-based cohort study. Journal of Allergy and Clinical Immunology: In Practice, 8(1), 248–257.e16. https://doi.org/10.1016/j.jaip.2019.08.030
Silverberg, J. I. (2019). Comorbidities and the impact of atopic dermatitis. Annals of Allergy, Asthma & Immunology, 123(2), 144–151. https://doi.org/10.1016/j.anai.2019.04.020
Talamonti, M., Galluzzo, M., Silvaggio, D., Lombardo, P., Tartaglia, C., & Bianchi, L. (2021). Quality of life and psychological impact in patients with atopic dermatitis. Journal of Clinical Medicine, 10(6), 1298. https://doi.org/10.3390/jcm10061298
Vinh, N. M., Trang, V. T. T., Thuy, L. N. D., Tam, H. T. X., Hang, L. T. T., & Van Bac, P. (2023). The anxiety and depression disorder in adults with atopic dermatitis: Experience of a dermatology hospital. Dermatology Reports, 15(1). https://doi.org/10.4081/dr.2022.9524
Vinnik, T., Kreinin, A., Abildinova, G., Batpenova, G., Kirby, M., & Pinhasov, A. (2020). Biological sex and IgE sensitization influence severity of depression and cortisol levels in atopic dermatitis. Dermatology, 236(4), 336–344. https://doi.org/10.1159/000504388
Weisshaar, E., Diepgen, T. L., Bruckner, T., Fartasch, M., Kupfer, J., Lobcorzilius, T., Ring, J., Scheewe, S., Scheidt, R., Schmid-Ott, G., Schnopp, C., Staab, D., Szczepanski, R., Werfel, T., Wittenmeier, M., Wahn, U., & Gieler, U. (2008). Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): Correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Dermato-Venereologica, 88(3), 234–239. https://doi.org/10.2340/00015555-0432
Yang, T., Chen, J., Zou, Q., Chen, S., Lin, Z., Yang, M., & Zhang, Y. (2025). Associations of anxiety and depression with skin symptoms and inflammatory cytokines in patients with atopic dermatitis. Actas Españolas de Psiquiatría, 53(5), 999–1010. https://doi.org/10.62641/aep.v53i5.1989
Zhang, X. J., Wang, A. P., Shi, T. Y., Zhang, J., Xu, H., Wang, D. Q., & Feng, L. (2019). The psychosocial adaptation of patients with skin disease: A scoping review. BMC Public Health, 19(1), Article 1404. https://doi.org/10.1186/s12889-019-7775-0
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Izabela Zuzanna Stranz, Anna Łęczycka, Kinga Haduch, Zuzanna Michalska, Nicole Aleksandra Ordyczyńska - Mardyła, Aleksandra Stańczyk, Olga Chorąży, Joanna Strzelczyk, Amelia Kędziora, Iga Suchta
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
